Literature DB >> 17592835

Dinuclear platinum complexes with biological relevance based on the 1,2-diaminocyclohexane carrier ligand.

John W Williams1, Yun Qu, Genevieve H Bulluss, Eugenio Alvorado, Nicholas P Farrell.   

Abstract

The synthesis of bifunctional dinuclear platinum complexes, [{PtCl(dach)}(2)-mu-Y](n+)Cl(n) (1-3; Y = H(2)N(CH(2))(3)NH(2)(CH(2))(4)NH(2), H(2)N(CH(2))(6)NH(2)(CH(2))(6)NH(2), and H(2)N(CH(2))(6)NH(2)(CH(2))(2)NH(2)(CH(2))(6)NH(2), respectively; Figure 1) is reported. There was no labilization of the polyamine linker groups of the cis-1,2-diaminocyclohexane complexes in the presence of sulfur-containing species at physiological pH, in contrast to previous studies preformed on trans complexes. Metabolism reactions are somewhat dependent on the nature of the polyamine: at physiological pH, the spermidine complex 1 forms an inert (tetraamine)platinum species in which one platinum is chelated by a central and terminal amino group. The stability of cis-geometry complexes may make them viable second-generation polynuclear platinum clinical candidates.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17592835     DOI: 10.1021/ic700410y

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  8 in total

1.  The trans influence in the modulation of platinum anticancer agent biology: the effect of nitrite leaving group on aquation, reactions with S-nucleophiles and DNA binding of dinuclear and trinuclear compounds.

Authors:  Eva I Montero; Junyong Zhang; Joseph J Moniodis; Susan J Berners-Price; Nicholas P Farrell
Journal:  Chemistry       Date:  2010-08-09       Impact factor: 5.236

2.  Effects of geometric isomerism and anions on the kinetics and mechanism of the stepwise formation of long-range DNA interstrand cross-links by dinuclear platinum antitumor complexes.

Authors:  Junyong Zhang; Donald S Thomas; Susan J Berners-Price; Nicholas Farrell
Journal:  Chemistry       Date:  2008       Impact factor: 5.236

3.  Thermodynamic stability and energetics of DNA duplexes containing major intrastrand cross-links of second-generation antitumor dinuclear Pt(II) complexes.

Authors:  Jakub Florian; Jana Kasparkova; Nicholas P Farrell; Viktor Brabec
Journal:  J Biol Inorg Chem       Date:  2011-09-06       Impact factor: 3.358

4.  Solution studies of dinuclear polyamine-linked platinum-based antitumour complexes.

Authors:  Rasha A Ruhayel; Ibrahim Zgani; Susan J Berners-Price; Nicholas P Farrell
Journal:  Dalton Trans       Date:  2011-03-08       Impact factor: 4.390

5.  Conformation and recognition of DNA modified by a new antitumor dinuclear PtII complex resistant to decomposition by sulfur nucleophiles.

Authors:  Lenka Zerzankova; Tereza Suchankova; Oldrich Vrana; Nicholas P Farrell; Viktor Brabec; Jana Kasparkova
Journal:  Biochem Pharmacol       Date:  2009-08-12       Impact factor: 5.858

6.  Ligand modulation of a dinuclear platinum compound leads to mechanistic differences in cell cycle progression and arrest.

Authors:  Vijay R Menon; Erica J Peterson; Kristoffer Valerie; Nicholas P Farrell; Lawrence F Povirk
Journal:  Biochem Pharmacol       Date:  2013-10-24       Impact factor: 5.858

7.  Mono and dinuclear platinum and palladium complexes containing adamantane-azole ligands: DNA and BSA interaction and cytotoxicity.

Authors:  Ana Luiza de Andrade Querino; Jessika Thayanne da Silva; Josiane Teixeira Silva; Gustavo Miguel Alvarenga; Carolina Hahn da Silveira; Mariana Torquato Quezado de Magalhães; Otávio Augusto Chaves; Bernardo Almeida Iglesias; Renata Diniz; Heveline Silva
Journal:  J Biol Inorg Chem       Date:  2019-10-16       Impact factor: 3.358

8.  Platinum nanoparticles induce damage to DNA and inhibit DNA replication.

Authors:  Lukas Nejdl; Jiri Kudr; Amitava Moulick; Dagmar Hegerova; Branislav Ruttkay-Nedecky; Jaromir Gumulec; Kristyna Cihalova; Kristyna Smerkova; Simona Dostalova; Sona Krizkova; Marie Novotna; Pavel Kopel; Vojtech Adam
Journal:  PLoS One       Date:  2017-07-12       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.